SCP Vitalife Partners (Israel) II, L.P.
CIK 0001602484 Name as filed on the most recent filing
Filed as SCP Vitalife Partners (Israel) II, L.P. (23)
41 transaction lines · from 23 filings · filed 2015-11-25 to 2020-12-28 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.
A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.
Issuers this insider has filed against
Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.
This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-20 05:22 UTC.
No issuer is recorded
The catalog holds no filing linking this CIK to an issuer.
Transactions
Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.
25 transactions · Newest transaction date first, id breaking the tie.
This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-20 05:22 UTC.
| Direction | Date | Issuer | Code | Shares | Price | Value USD | Filing |
|---|---|---|---|---|---|---|---|
| 2020-12-22 |
Recro Pharma, Inc. REPH |
S, Open-market sale | 18,830 disposed | 3.17 | 59,691.10 | Form 4, filing 0001192482-20-000850 | |
| 2020-12-18 |
Recro Pharma, Inc. REPH |
S, Open-market sale | 6,208 disposed | 3.03 | 18,812.72 | Form 4, filing 0001192482-20-000846 | |
| 2018-01-04 |
Recro Pharma, Inc. REPH |
S, Open-market sale | 1,579 disposed | 8.84 | 13,955.52 | Form 4, filing 0001192482-18-000033 | |
| 2018-01-03 |
Recro Pharma, Inc. REPH |
S, Open-market sale | 6,635 disposed | 8.73 | 57,943.46 | Form 4, filing 0001192482-18-000010 | |
| 2018-01-02 |
Recro Pharma, Inc. REPH |
S, Open-market sale | 6,329 disposed | 9.04 | 57,195.17 | Form 4, filing 0001192482-18-000010 | |
| 2017-12-29 |
Recro Pharma, Inc. REPH |
S, Open-market sale | 4,110 disposed | 9.19 | 37,790.63 | Form 4, filing 0001192482-18-000002 | |
| 2017-12-28 |
Recro Pharma, Inc. REPH |
S, Open-market sale | 1,980 disposed | 9.44 | 18,690.21 | Form 4, filing 0001192482-18-000002 | |
| 2017-12-27 |
Recro Pharma, Inc. REPH |
S, Open-market sale | 2,803 disposed | 9.54 | 26,737.26 | Form 4, filing 0001192482-17-000329 | |
| 2017-12-26 |
Recro Pharma, Inc. REPH |
S, Open-market sale | 1,602 disposed | 9.59 | 15,364.14 | Form 4, filing 0001192482-17-000329 | |
| 2017-06-27 |
ReWalk Robotics Ltd. RWLK |
S, Open-market sale | 12,511 disposed | 3.09 | 38,697.77 | Form 4, filing 0001144204-17-034636 | |
| 2017-06-26 |
ReWalk Robotics Ltd. RWLK |
S, Open-market sale | 9,271 disposed | 3.00 | 27,813.00 | Form 4, filing 0001144204-17-034636 | |
| 2017-03-16 |
Recro Pharma, Inc. REPH |
S, Open-market sale | 3,170 disposed | 7.93 | 25,124.79 | Form 4, filing 0001123292-17-000694 | |
| 2017-03-15 |
Recro Pharma, Inc. REPH |
S, Open-market sale | 6,399 disposed | 8.01 | 51,270.07 | Form 4, filing 0001123292-17-000694 | |
| 2017-03-14 |
Recro Pharma, Inc. REPH |
S, Open-market sale | 5,454 disposed | 8.04 | 43,847.98 | Form 4, filing 0001123292-17-000694 | |
| 2017-02-17 |
Recro Pharma, Inc. REPH |
S, Open-market sale | 3,334 disposed | 7.59 | 25,311.73 | Form 4, filing 0001123292-17-000452 | |
| 2017-02-16 |
Recro Pharma, Inc. REPH |
S, Open-market sale | 1,100 disposed | 7.86 | 8,642.92 | Form 4, filing 0001123292-17-000445 | |
| 2017-02-15 |
Recro Pharma, Inc. REPH |
S, Open-market sale | 2,164 disposed | 7.88 | 17,052.32 | Form 4, filing 0001123292-17-000445 | |
| 2017-02-14 |
Recro Pharma, Inc. REPH |
S, Open-market sale | 766 disposed | 7.96 | 6,094.22 | Form 4, filing 0001123292-17-000445 | |
| 2017-02-13 |
Recro Pharma, Inc. REPH |
S, Open-market sale | 2,651 disposed | 7.97 | 21,129.53 | Form 4, filing 0001123292-17-000428 | |
| 2016-08-16 |
ReWalk Robotics Ltd. RWLK |
S, Open-market sale | 12,519 disposed | 6.29 | 78,770.80 | Form 4, filing 0001144204-16-120030 | |
| 2016-08-16 |
ReWalk Robotics Ltd. RWLK |
S, Open-market sale | 1,561 disposed | 6.42 | 10,023.65 | Form 4, filing 0001144204-16-120030 | |
| 2016-08-15 |
ReWalk Robotics Ltd. RWLK |
S, Open-market sale | 10,958 disposed | 6.45 | 70,660.47 | Form 4, filing 0001144204-16-120030 | |
| 2016-06-03 |
ReWalk Robotics Ltd. RWLK |
S, Open-market sale | 1,324 disposed | 7.90 | 10,454.44 | Form 4, filing 0001144204-16-107109 | |
| 2016-06-02 |
ReWalk Robotics Ltd. RWLK |
S, Open-market sale | 3,448 disposed | 7.89 | 27,208.51 | Form 4, filing 0001144204-16-107109 | |
| 2016-06-01 |
ReWalk Robotics Ltd. RWLK |
S, Open-market sale | 1,570 disposed | 7.58 | 11,898.72 | Form 4, filing 0001144204-16-106508 | |
| 2016-05-31 |
ReWalk Robotics Ltd. RWLK |
S, Open-market sale | 1,277 disposed | 7.94 | 10,140.66 | Form 4, filing 0001144204-16-106508 | |
| 2016-05-26 |
ReWalk Robotics Ltd. RWLK |
S, Open-market sale | 3,756 disposed | 8.61 | 32,328.27 | Form 4, filing 0001144204-16-105624 | |
| 2016-05-25 |
ReWalk Robotics Ltd. RWLK |
S, Open-market sale | 3,010 disposed | 8.80 | 26,479.57 | Form 4, filing 0001144204-16-105624 | |
| 2016-05-24 |
ReWalk Robotics Ltd. RWLK |
S, Open-market sale | 50 disposed | 8.95 | 447.50 | Form 4, filing 0001144204-16-104905 | |
| 2016-05-23 |
Recro Pharma, Inc. REPH |
S, Open-market sale | 2,503 disposed | 6.30 | 15,769.15 | Form 4, filing 0001123292-16-002338 | |
| 2016-05-23 |
ReWalk Robotics Ltd. RWLK |
S, Open-market sale | 300 disposed | 9.00 | 2,700.00 | Form 4, filing 0001144204-16-104905 | |
| 2016-05-20 |
ReWalk Robotics Ltd. RWLK |
S, Open-market sale | 2,791 disposed | 9.08 | 25,338.93 | Form 4, filing 0001144204-16-104288 | |
| 2016-05-20 |
Recro Pharma, Inc. REPH |
S, Open-market sale | 5,008 disposed | 6.45 | 32,325.64 | Form 4, filing 0001123292-16-002312 | |
| 2016-05-19 |
ReWalk Robotics Ltd. RWLK |
S, Open-market sale | 1,252 disposed | 9.12 | 11,416.99 | Form 4, filing 0001144204-16-104288 | |
| 2016-05-19 |
Recro Pharma, Inc. REPH |
S, Open-market sale | 1,252 disposed | 6.46 | 8,082.79 | Form 4, filing 0001123292-16-002312 | |
| 2016-01-15 |
ReWalk Robotics Ltd. RWLK |
S, Open-market sale | 12,519 disposed | 10.30 | 128,905.64 | Form 4, filing 0001144204-16-076262 | |
| 2015-11-30 |
Recro Pharma, Inc. REPH |
S, Open-market sale | 150 disposed | 9.00 | 1,350.00 | Form 4, filing 0001192482-15-000430 | |
| 2015-11-27 |
Recro Pharma, Inc. REPH |
S, Open-market sale | 2,250 disposed | 9.00 | 20,252.02 | Form 4, filing 0001192482-15-000429 | |
| 2015-11-25 |
Recro Pharma, Inc. REPH |
S, Open-market sale | 1,553 disposed | 9.00 | 13,977.00 | Form 4, filing 0001192482-15-000429 | |
| 2015-11-24 |
Recro Pharma, Inc. REPH |
S, Open-market sale | 691 disposed | 9.01 | 6,223.15 | Form 4, filing 0001192482-15-000426 | |
| 2015-11-23 |
Recro Pharma, Inc. REPH |
S, Open-market sale | 3,702 disposed | 9.00 | 33,321.33 | Form 4, filing 0001192482-15-000426 |
This column is intentionally blank
No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.
- S, Open-market sale
- Open-market sale
Every value is as reported on the Form 4. A price the filing did not report is marked Not reported and no value is computed from it. Codes outside the open market, drawn in grey behind a dashed rule, are compensation and administrative machinery rather than a decision to trade at the prevailing price.
What this insider's stored lines contain
Exact counts over every stored line for this entity. This is a statement of composition, not a filter: the only filter this page offers is the open-market one above, because that is the only one an index serves today.
- Open-market purchase 0
- Open-market sale 25
- Option exercise 0
- Grant or award 0
- Tax withholding 0
- Disposition to the issuer 0
- In-the-money option exercise 0
How to cite this page
ebomi catalog. SCP Vitalife Partners (Israel) II, L.P., insider transactions. Retrieved 2026-08-20 from https://ebomi.com/insider/0001602484
Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6